dc.creatorBaudrit Carrillo, Olga
dc.creatorBaltodano Viales, Eleaneth
dc.creatorJiménez Herrera, Luis Guillermo
dc.date.accessioned2017-12-20T21:32:05Z
dc.date.accessioned2022-10-19T23:46:56Z
dc.date.available2017-12-20T21:32:05Z
dc.date.available2022-10-19T23:46:56Z
dc.date.created2017-12-20T21:32:05Z
dc.date.issued2016
dc.identifierhttp://www.wjpr.net/dashboard/abstract_id/5556
dc.identifier2277-7105
dc.identifierhttps://hdl.handle.net/10669/73723
dc.identifier10.20959/wjpr2016 8-6766
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4523671
dc.description.abstractNot always people receive the just dose of active ingredient required for his health problem. To obtain success in pharmacology treatment, sometimes the physicians prescribe drugs in a dose that is impossible obtain in the market because this specific strength does not exist in the pharmaceutical form that they proposed. This is the case of some tablets, which need to be divided to achieve this objective. Several reasons are to justify the need to split pills, since there exist some consequences of this act in different contexts. Laboratories produce pharmaceutical forms with Good Manufacturing Practices, but not all medications are designed to be split. Dividing a scored tablet into two parts, it is no guarantee to find accurately the half dose in each fraction. More research is required in Costa Rica, Central America to know the magnitude of the actual situation in this topic.
dc.languageen_US
dc.sourceWorld Journal of Pharmaceutical Research, Vol 5 (8), pp. 91-107
dc.subjectSplit tablets
dc.subjectFractionation
dc.subjectDrugs
dc.subjectDosage forms
dc.subjectPharmaceutical
dc.titleReview of the fractionation of medicines available in solid formulations (tablets)
dc.typeartículo científico


Este ítem pertenece a la siguiente institución